title: Value of Information in Asia: Concepts, Current Use, and Future Directions.
abstract: Health technology assessment is a form of health policy research that provides policymakers with information relevant to decisions about policy alternatives. Findings from cost-effectiveness analysis (CEA) are one of the important aspects of health technology assessment. Nevertheless, the more advanced method of value of information (VOI), which is recommended by the International Society for Pharmacoeconomics and Outcomes Research and Society for Medical Decision Making Modeling Good Research Practices Task Force, has rarely been applied in CEA studies in Asia. The lack of VOI in Asian CEA studies may be due to limited understanding of VOI methods and what VOI can and cannot help policy decision makers accomplish. This concept article offers audiences a practical primer in understanding the calculation, presentation, and policy implications of VOI. In addition, it provides a rapid survey of health technology assessment guidelines and literature related to VOI in Asia and discusses the future directions of VOI use in Asia and its potential barriers. This article will enable health economists, outcomes researchers, and policymakers in Asia to better understand the importance of VOI analysis and its implications, leading to the appropriate use of VOI in Asia.
authors.affiliation: Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Faculty of Pharmaceutical Sciences, Department of Pharmacy Practice, Center of Pharmaceutical Outcomes Research, Naresuan University, Phitsanulok, Thailand. Electronic address: piyamethd@gmail.com.
authors.forename: Piyameth
authors.initials: P
authors.lastname: Dilokthornsakul
authors.affiliation: Research in Real Life (RiRL), Cambridge, UK.
authors.forename: R Brett
authors.initials: RB
authors.lastname: McQueen
authors.affiliation: Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selaton, 47500 Bandar Sunway, Selangor Darul Ehsan, Malaysia; School of Population Health, University of Queensland, Brisbane, Queensland, Australia; School of Pharmacy, University of Wisconsin-Madison, Madison, WI, USA.
authors.forename: Nathorn
authors.initials: N
authors.lastname: Chaiyakunapruk
authors.affiliation: Department of Community Health Sciences, University of Calgary, Calgary, Canada.
authors.forename: Eldon
authors.initials: E
authors.lastname: Spackman
authors.affiliation: Division of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, USA.
authors.forename: Jonathan H
authors.initials: JH
authors.lastname: Watanabe
authors.affiliation: Center for Pharmaceutical Outcomes Research, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Campbell
mesh_terms: D001208:Asia; D003362:Cost-Benefit Analysis; D003657:Decision Making; D017850:Economics, Pharmaceutical; D006291:Health Policy; D017063:Outcome Assessment, Health Care; D011050:Policy Making; D012107:Research Design; D013673:Technology Assessment, Biomedical
keywords: Asia; cost-effectiveness analysis; value of information